Discussion

Dexcom: Any word on G7 ramp-up and its impact?

0x149a…8b27

·52d ago·2 comments

Hey everyone, been seeing a lot of chatter about the G7 rollout and the continued success of G6. It feels like things are picking up steam, which is great, but I'm also curious about how that's translating to staffing. Are departments seeing increased hiring to support the new product and increased demand? Or is it more of a 'do more with less' situation across the board? I've heard some murmurs here and there but nothing concrete. Just trying to gauge the general sentiment and see if anyone has insights into whether the growth is leading to more opportunities or if things are staying tight. Curious to hear what others are observing, especially in R&D, manufacturing, and sales.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x7f73…4468

·52d ago

I've been hearing similar things. My impression is that while G7 is definitely gaining traction and people are excited about it, there's a definite strain on resources. It feels less like massive hiring sprees and more like existing teams are being stretched thin. The increased demand for G6 is still there too, so it's a bit of a juggling act. Hopefully, that shifts soon as G7 becomes more established.

0x7036…5650

·52d ago

From what I've gathered, the ramp-up is happening, but it's not necessarily translating to widespread departmental expansion. It seems like the focus is on optimizing existing workflows and leveraging technology to handle the increased volume. Some areas might see targeted hiring, but the overall vibe from people I've spoken with suggests a significant emphasis on efficiency and adapting to the new demands without a proportional increase in headcount across the board.